Last update 08 May 2025

RGH-706

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
MCHR1
Action
inhibitors
Mechanism
MCHR1 inhibitors(Melanin-concentrating hormone receptor 1 inhibitors)
Therapeutic Areas
Nervous System DiseasesCongenital DisordersEndocrinology and Metabolic Disease+ [1]
Active Indication
Prader-Willi Syndrome
Inactive Indication-
Originator Organization
Gedeon Richter (UK) Ltd.
Active Organization
Chemical Works of Gedeon Richter PlcChemical Works of Gedeon Richter Plc
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with RGH-706
NCT05322096
/ CompletedPhase 2
A Randomized, Double-blind, Placebo-controlled, Multi-center, Phase 2 Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome
100 Clinical Results associated with RGH-706
Login to view more data
100 Translational Medicine associated with RGH-706
Login to view more data
100 Patents (Medical) associated with RGH-706
Login to view more data
100 Deals associated with RGH-706
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Prader-Willi SyndromePhase 2
Spain
Chemical Works of Gedeon Richter PlcChemical Works of Gedeon Richter Plc
22 Sep 2022
Prader-Willi SyndromePhase 2
United States
Chemical Works of Gedeon Richter PlcChemical Works of Gedeon Richter Plc
22 Sep 2022
Prader-Willi SyndromePhase 2
Italy
Chemical Works of Gedeon Richter PlcChemical Works of Gedeon Richter Plc
22 Sep 2022
Prader-Willi SyndromePhase 2
Czechia
Chemical Works of Gedeon Richter PlcChemical Works of Gedeon Richter Plc
22 Sep 2022
Prader-Willi SyndromePhase 2
France
Chemical Works of Gedeon Richter PlcChemical Works of Gedeon Richter Plc
22 Sep 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free